We are live on ! Find out more
CYTXW

Cytori Therapeutics Inc Warrant
CYTXW

Delisted

CYTXW was delisted on the 14th of December, 2018.

Back to rankings

4 hedge funds and large institutions have $769K invested in Cytori Therapeutics Inc Warrant in 2017 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more funds holding

Funds holding: 3 → 4 (+1)

13% less capital invested

Capital invested by funds: $880K → $769K (-$111K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
4
Holders Change
+1
Holders Change %
+33.33%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
MCM
Manchester Capital Management
Vermont
+$5

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$8.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$757K -$8.5K -12,065 -0.9%
Creative Planning
2
Creative Planning
Kansas
$12K – – –
MCM
3
Manchester Capital Management
Vermont
– +$5 +7 New

CYTXW Hedge Fund Activity: Q1 2017 in Review

4 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Cytori Therapeutics Inc Warrant (CYTXW) for Q1 2017, worth a combined $769K — down 13% from $880K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new CYTXW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Manchester Capital Management, opening a new position worth an estimated $5. The largest seller was Sabby Management, cutting an estimated $8.5K.

  • 4 institutional investors held Cytori Therapeutics Inc Warrant (CYTXW) as of Q1 2017, up from 3 in Q4 2016.
  • Funds reported $769K of Cytori Therapeutics Inc Warrant stock for Q1 2017, down 13% quarter-over-quarter.
  • 1 fund opened new Cytori Therapeutics Inc Warrant positions in Q1 2017 and 0 closed out, a net change of +1 holder.
  • The largest Cytori Therapeutics Inc Warrant buyer in Q1 2017 was Manchester Capital Management, an estimated $5 added.
  • The largest Cytori Therapeutics Inc Warrant seller in Q1 2017 was Sabby Management, an estimated $8.5K sold.

Based on aggregated 13F filings for Q1 2017.